Literature DB >> 32599618

ABIN3 negatively regulates necroptosis-induced intestinal inflammation through recruiting A20 and restricting the ubiquitination of RIPK3 in inflammatory bowel disease.

Mingxia Zhou1,2, Jing He3, Yingying Shi1,2, Xiaoman Liu1,2, Shangjian Luo1,2, Cheng Cheng2, Wensong Ge1, Chunying Qu1, Peng Du4, Yingwei Chen1,2.   

Abstract

BACKGROUND AND AIMS: There is evidence for a disturbed necroptosis function in many inflammatory diseases but its role in inflammatory bowel diseases (IBD) and the underlying mechanisms are unclear. Here, we studied the functional significance and molecular mechanisms of ABIN3, a ubiquitin-binding protein, in regulating the ubiquitination and activation of necroptosis in IBD.
METHODS: The expression of necroptosis hallmarks and ABIN3 were assessed in inflamed samples of IBD patients, dextran sodium sulfate (DSS)-induced colitis models and azoxymethane (AOM)/DSS models in mice. ABIN3 were overexpressed and silenced to explore its function in regulating necroptosis, inflammation and intestinal barrier function. Immuoprecipitiation (IP) and co-IP assays were performed to investigate the crosstalk between ABIN3 and deubiquitinating enzyme A20, and the mechanisms of coordinating ubiquitination modification to regulate necroptosis.
RESULTS: Excessive necroptosis is an important contributory factor towards the uncontrolled inflammation and intestinal barrier defects in IBD and experimental colitis. Blocking necroptosis by Nec-1s or GSK'872 significantly prevented cell death and alleviated DSS-induced colitis in vivo, whereas in AOM/DSS model, necroptosis inhibitors aggravated the severity of colitis-associated colon carcinogenesis (CAC). Mechanistically, ABIN3 is rapidly recruited to the TNF-RSC complex, which interacts and coordinates with deubiquitinating enzyme A20 to control the K63 deubiquitination modification and subsequent activation of the critical necroptosis kinase, RIPK3, to suppress necroptosis.
CONCLUSIONS: ABIN3 regulates inflammatory response and intestinal barrier function by interacting with A20 and coordinating the K63 deubiquitination modification of necroptosis in IBD. Published by Oxford University Press on behalf of European Crohn’s and Colitis Organisation (ECCO) 2020. This work is written by US Government employee and is in the public domain in the US.

Entities:  

Keywords:  A20; ABIN3; Necroptosis; RIPK3; inflammation; intestinal barrier; ubiquitination

Year:  2020        PMID: 32599618     DOI: 10.1093/ecco-jcc/jjaa131

Source DB:  PubMed          Journal:  J Crohns Colitis        ISSN: 1873-9946            Impact factor:   9.071


  8 in total

Review 1.  RIPK3 signaling and its role in the pathogenesis of cancers.

Authors:  Shanhui Liu; Kanak Joshi; Mitchell F Denning; Jiwang Zhang
Journal:  Cell Mol Life Sci       Date:  2021-10-15       Impact factor: 9.207

Review 2.  Advances in the Study of the Ubiquitin-Editing Enzyme A20.

Authors:  Wenya Bai; Siying Huo; Junjie Li; Jianlin Shao
Journal:  Front Pharmacol       Date:  2022-05-03       Impact factor: 5.988

Review 3.  Targeting RIP Kinases in Chronic Inflammatory Disease.

Authors:  Mary Speir; Tirta M Djajawi; Stephanie A Conos; Hazel Tye; Kate E Lawlor
Journal:  Biomolecules       Date:  2021-04-28

4.  RIP3 knockdown inhibits necroptosis of human intestinal epithelial cells via TLR4/MyD88/NF-κB signaling and ameliorates murine colitis.

Authors:  Chaoqin Duan; Xi Xu; Xiaoyi Lu; Ling Wang; Zhongkai Lu
Journal:  BMC Gastroenterol       Date:  2022-03-26       Impact factor: 3.067

5.  ABIN1 Inhibits Inflammation through Necroptosis-Dependent Pathway in Ulcerative Colitis.

Authors:  Jing Bao; Bin Ye; Yuhan Ren
Journal:  Genet Res (Camb)       Date:  2022-08-08       Impact factor: 1.375

Review 6.  Necroptosis in Intestinal Inflammation and Cancer: New Concepts and Therapeutic Perspectives.

Authors:  Anna Negroni; Eleonora Colantoni; Salvatore Cucchiara; Laura Stronati
Journal:  Biomolecules       Date:  2020-10-10

Review 7.  The Role of E3 Ubiquitin Ligases and Deubiquitinases in Inflammatory Bowel Disease: Friend or Foe?

Authors:  Min Zou; Qi-Shan Zeng; Jiao Nie; Jia-Hui Yang; Zhen-Yi Luo; Hua-Tian Gan
Journal:  Front Immunol       Date:  2021-12-08       Impact factor: 7.561

8.  Salmonella pSLT-encoded effector SpvB promotes RIPK3-dependent necroptosis in intestinal epithelial cells.

Authors:  Kedi Dong; Yuan Zhu; Qifeng Deng; Lanqing Sun; Sidi Yang; Kai Huang; Yu Cao; Yuanyuan Li; Shuyan Wu; Rui Huang
Journal:  Cell Death Discov       Date:  2022-02-02
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.